These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. Alam H; Maizels ET; Park Y; Ghaey S; Feiger ZJ; Chandel NS; Hunzicker-Dunn M J Biol Chem; 2004 May; 279(19):19431-40. PubMed ID: 14982927 [TBL] [Abstract][Full Text] [Related]
24. Stabilization of hypoxia-inducible factor-1alpha is involved in the hypoxic stimuli-induced expression of vascular endothelial growth factor in osteoblastic cells. Kim HH; Lee SE; Chung WJ; Choi Y; Kwack K; Kim SW; Kim MS; Park H; Lee ZH Cytokine; 2002 Jan; 17(1):14-27. PubMed ID: 11886167 [TBL] [Abstract][Full Text] [Related]
25. Regulation of vascular endothelial growth factor expression by advanced glycation end products. Treins C; Giorgetti-Peraldi S; Murdaca J; Van Obberghen E J Biol Chem; 2001 Nov; 276(47):43836-41. PubMed ID: 11571295 [TBL] [Abstract][Full Text] [Related]
26. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines. Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908 [TBL] [Abstract][Full Text] [Related]
27. Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells. Mayerhofer M; Aichberger KJ; Florian S; Krauth MT; Hauswirth AW; Derdak S; Sperr WR; Esterbauer H; Wagner O; Marosi C; Pickl WF; Deininger M; Weisberg E; Druker BJ; Griffin JD; Sillaber C; Valent P FASEB J; 2005 Jun; 19(8):960-2. PubMed ID: 15784722 [TBL] [Abstract][Full Text] [Related]
28. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Görlach A; Diebold I; Schini-Kerth VB; Berchner-Pfannschmidt U; Roth U; Brandes RP; Kietzmann T; Busse R Circ Res; 2001 Jul; 89(1):47-54. PubMed ID: 11440977 [TBL] [Abstract][Full Text] [Related]
29. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Sodhi A; Montaner S; Patel V; Zohar M; Bais C; Mesri EA; Gutkind JS Cancer Res; 2000 Sep; 60(17):4873-80. PubMed ID: 10987301 [TBL] [Abstract][Full Text] [Related]
30. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Welsh SJ; Bellamy WT; Briehl MM; Powis G Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766 [TBL] [Abstract][Full Text] [Related]
31. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Nakamura K; Martin KC; Jackson JK; Beppu K; Woo CW; Thiele CJ Cancer Res; 2006 Apr; 66(8):4249-55. PubMed ID: 16618748 [TBL] [Abstract][Full Text] [Related]
32. Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides. Aichberger KJ; Mayerhofer M; Krauth MT; Skvara H; Florian S; Sonneck K; Akgul C; Derdak S; Pickl WF; Wacheck V; Selzer E; Monia BP; Moriggl R; Valent P; Sillaber C Blood; 2005 Apr; 105(8):3303-11. PubMed ID: 15626746 [TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. Phillips RJ; Mestas J; Gharaee-Kermani M; Burdick MD; Sica A; Belperio JA; Keane MP; Strieter RM J Biol Chem; 2005 Jun; 280(23):22473-81. PubMed ID: 15802268 [TBL] [Abstract][Full Text] [Related]
34. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233 [TBL] [Abstract][Full Text] [Related]
35. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene. Liu MY; Poellinger L; Walker CL Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296 [TBL] [Abstract][Full Text] [Related]